Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Laser treatment increases hair density and thickness safely in women with hair loss.

Aconiti Ciliare Tuber extract may help hair grow by activating a specific cell signaling pathway.

ECM molecules are crucial for hair growth and development.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Healthy women tend to lose more hair in July and April, and the least in February.

Finasteride shows promise for female hair loss, but more research needed.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Combination therapy works best for female hair loss, increasing density and thickness.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Terbinafine can cause hair loss.

Hair loss might be due to nerve issues, treatable with electric stimulation or acupuncture.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

The dermal papilla is crucial for hair growth and health, and understanding it could lead to new hair loss treatments.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

One minoxidil-sensitive potassium channel exists in human hair follicles.